Abstract:
Bioprosthetic valve thrombosis is a growing recognized entity, especially with the increasing use of the valve in vale procedures and the advent of new detection technologies (e.g., 4D CT and 4D echocardiography). However, the optimal management strategy in the acute context is not established. This paper presents a case of early thrombosis following the percutaneous tricuspid valve in vale procedure that was successfully managed with thrombolysis.
Keywords: bioprosthetic valve thrombosis, percutaneous valve in valve procedure, fibrinolysis, transesophageal echocardiography
Introduction:
Bioprosthetic Valves are generally considered to be less thrombogenic than mechanical valves. With an increased attitude for transcatheter heart valve implantation, which precludes high-risk cardiac reoperations, and evolving use of 4D echocardiography and computed tomography, the prevalence and recognition of bioprosthetic valve thrombosis(BPVT) are increasing. Prevention and optimal management of this condition, particularly in an acute setting, has not been fully elucidated. Herein we present a case of early thrombosis following transcatheter tricuspid valve in valve implantation that was favorably managed by thrombolysis.